Target intelligence / Profile preview

Vascular smooth muscle Ca2+-dependent ATPase and myosin light chain phosphorylation machinery

Molecular classification
Enzyme, Kinase, ATPase, Transporter
01

Overview

The vascular smooth muscle Ca2+-dependent ATPase and the myosin light chain phosphorylation machinery represent the integrated biochemical system responsible for regulating blood vessel diameter and peripheral resistance. The primary ATPase involved is the Sarcoplasmic/Endoplasmic Reticulum Calcium ATPase (SERCA2), which actively transports calcium ions from the cytosol into the sarcoplasmic reticulum to facilitate muscle relaxation [UniProt, 2023]. The phosphorylation machinery is centered on Myosin Light Chain Kinase (MLCK), an enzyme that becomes active upon binding to the Ca2+-calmodulin complex [Kamm & Stull, 1985]. Once active, MLCK phosphorylates the 20-kDa regulatory light chain of myosin, enabling cross-bridge formation with actin and resulting in vasoconstriction [Webb, 2003]. This process is balanced by Myosin Light Chain Phosphatase (MLCP), which promotes relaxation by removing the phosphate group, a process regulated by the Rho-kinase pathway [Somlyo & Somlyo, 2003]. Dysregulation of this system, often characterized by increased MLCK activity or decreased SERCA function, is a fundamental mechanism in the pathogenesis of hypertension and vasospastic disorders [PubMed, 2018]. Pharmacological agents like magnesium sulfate, nitrates, and Rho-kinase inhibitors target various points in this machinery to modulate vascular tone and treat cardiovascular conditions.

Other names
Smooth muscle contractile apparatusMLCK-SERCA regulatory axisCa2+-calmodulin-MLCK pathwayVascular contractile machinery
02

Mechanism of action

Regulation of vascular smooth muscle tone through the control of intracellular calcium levels (via ATPase-mediated sequestration) and the phosphorylation state of the myosin light chain (via kinase/phosphatase activity).

03

Biological functions

Muscle contractionCalcium signalingVascular tone regulation
04

Disease associations

HypertensionCardiovascular diseaseAsthmaVasospasmPreeclampsia
05

Safety considerations

Systemic hypotensionImpaired gastrointestinal motilityPotential for cardiac toxicity if SERCA isoforms are non-selectively targetedCompromised immune cell migration
06

Interacting drugs

Magnesium sulfate

5 more in the full profile.

07

Biomarkers

Phosphorylated myosin light chain (p-MLC) levelsIntracellular calcium concentrationMLCK activity

Beyond the preview

Go deeper on Vascular smooth muscle Ca2+-dependent ATPase and myosin light chain phosphorylation machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vascular smooth muscle Ca2+-dependent ATPase and myosin light chain phosphorylation machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call